Pacific Capital Wealth Advisors Inc. Sells 11,951 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Pacific Capital Wealth Advisors Inc. cut its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 18.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 51,744 shares of the financial services provider’s stock after selling 11,951 shares during the quarter. iShares Biotechnology ETF makes up about 1.8% of Pacific Capital Wealth Advisors Inc.’s investment portfolio, making the stock its 13th largest position. Pacific Capital Wealth Advisors Inc.’s holdings in iShares Biotechnology ETF were worth $7,029,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of IBB. Glass Jacobson Investment Advisors llc grew its position in iShares Biotechnology ETF by 150.6% during the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after acquiring an additional 122 shares during the last quarter. Values First Advisors Inc. purchased a new position in iShares Biotechnology ETF in the 4th quarter worth $43,000. Tennessee Valley Asset Management Partners bought a new stake in iShares Biotechnology ETF in the fourth quarter worth $44,000. Massmutual Trust Co. FSB ADV lifted its stake in iShares Biotechnology ETF by 164.2% in the fourth quarter. Massmutual Trust Co. FSB ADV now owns 362 shares of the financial services provider’s stock worth $49,000 after purchasing an additional 225 shares during the last quarter. Finally, CVA Family Office LLC purchased a new stake in iShares Biotechnology ETF during the fourth quarter valued at about $51,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 0.5 %

Shares of IBB traded down $0.69 during trading hours on Wednesday, hitting $132.59. The company had a trading volume of 1,257,456 shares, compared to its average volume of 1,792,102. iShares Biotechnology ETF has a 52-week low of $111.83 and a 52-week high of $141.16. The stock’s 50 day moving average price is $133.33 and its 200 day moving average price is $130.34.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were paid a $0.126 dividend. The ex-dividend date was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.38%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.